Vitamin D and triamcinolone for plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This early study tests whether taking vitamin D together with triamcinolone (a steroid used on skin) works better for plaque psoriasis than a standard approach. It aims to see if the combination helps clear psoriasis plaques and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have plaque psoriasis that your doctor rates as mild to severe
- Not be on psoriasis treatments that change the immune system or most pill/biologic medicines within the past 28 days (or longer for some)
- Avoid phototherapy and tanning/extra sun for the set time before starting
- Use no medicated psoriasis skin creams for the set time before starting
- Have normal health history for kidneys, calcium/parathyroid balance, and bone health (no kidney impairment, kidney stones, parathyroid problems, or osteoporosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
This study tests an investigational tablet called ASC50 for plaque psoriasis. It aims to see if it is safe and works well for people with this skin condition.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study tests an experimental oral medication (a TYK2 inhibitor) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing psoriasis symptoms.
This trial tests whether a combination of two drugs (vunakizumab and recaticimab) can help people who have both moderate-to-severe plaque psoriasis and high cholesterol. It aims to see if the treatment is safe and effective for both conditions.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.